- Report
- November 2024
- 150 Pages
Global
From €4410EUR$4,850USD£3,792GBP
- Report
- August 2025
- 150 Pages
Global
From €2873EUR$3,160USD£2,470GBP
€3592EUR$3,950USD£3,088GBP
- Report
- August 2025
- 150 Pages
Global
From €2873EUR$3,160USD£2,470GBP
€3592EUR$3,950USD£3,088GBP
- Report
- September 2025
- 150 Pages
Global
From €4046EUR$4,450USD£3,479GBP
- Report
- September 2025
- 150 Pages
Global
From €4046EUR$4,450USD£3,479GBP
- Report
- September 2025
- 97 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- September 2025
- 104 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- May 2025
- 82 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- May 2025
- 101 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- May 2025
- 93 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- March 2025
- 103 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- January 2025
- 98 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- January 2025
- 85 Pages
Global
From €3500EUR$4,123USD£3,114GBP
- Report
- October 2025
- 80 Pages
Saudi Arabia
From €4092EUR$4,500USD£3,518GBP
- Report
- September 2025
- 94 Pages
Global
From €16363EUR$17,995USD£14,068GBP
- Report
- July 2025
- 75 Pages
Global
From €16363EUR$17,995USD£14,068GBP
- Report
- March 2025
- 74 Pages
Global
From €16363EUR$17,995USD£14,068GBP
- Report
- March 2025
- 201 Pages
China
From €3637EUR$4,000USD£3,127GBP
- Report
- August 2024
- 238 Pages
China
From €3637EUR$4,000USD£3,127GBP
- Report
- October 2023
- 85 Pages
United States
From €4092EUR$4,500USD£3,518GBP

The Immune Disorders Drugs market is composed of drugs used to treat a variety of conditions related to the immune system. These drugs are used to treat autoimmune diseases, allergies, and other conditions that affect the body's ability to fight off infection. Inflammation drugs are a subset of these drugs, used to reduce inflammation and swelling caused by an immune response. These drugs can be used to treat a variety of conditions, including rheumatoid arthritis, psoriasis, and Crohn's disease. They can also be used to reduce the risk of infection in patients with weakened immune systems.
Inflammation drugs are typically administered orally or intravenously, and can be taken as a single dose or as part of a longer-term treatment plan. Common side effects of these drugs include nausea, vomiting, and diarrhea.
Companies in the Immune Disorders Drugs market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more